scispace - formally typeset
N

Nancy Francoeur

Researcher at Icahn School of Medicine at Mount Sinai

Publications -  36
Citations -  2544

Nancy Francoeur is an academic researcher from Icahn School of Medicine at Mount Sinai. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 12, co-authored 26 publications receiving 1888 citations. Previous affiliations of Nancy Francoeur include Beth Israel Deaconess Medical Center & New York University.

Papers
More filters
Journal ArticleDOI

Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.

TL;DR: The BRCAness profile correlates with responsiveness to platinum and PARP inhibitors and identifies a subset of sporadic patients with improved outcome and is validated in 70 patients enriched for sporadic disease.
Journal ArticleDOI

The PsychENCODE project

Schahram Akbarian, +85 more
- 25 Nov 2015 - 
TL;DR: The PsychENCODE project aims to produce a public resource of multidimensional genomic data using tissue- and cell type–specific samples from approximately 1,000 phenotypically well-characterized, high-quality healthy and disease-affected human post-mortem brains, as well as functionally characterize disease-associated regulatory elements and variants in model systems.
Journal ArticleDOI

Large eQTL meta-analysis reveals differing patterns between cerebral cortical and cerebellar brain regions.

Solveig K. Sieberts, +100 more
- 12 Oct 2020 - 
TL;DR: A colocalization analysis is applied to identify genes underlying the GWAS association peaks for schizophrenia and identify a potentially novel gene colocalized with lncRNA RP11-677M14.
Journal ArticleDOI

Keap1 mutations and Nrf2 pathway activation in epithelial ovarian cancer.

TL;DR: Patients with evidence of Nrf2 pathway activation had fewer complete clinical responses to platinum-based therapy, were enriched for platinum resistance, and had shorter median overall survival compared with those who did not show evidence of EOC pathway activation.